Specialized Canagliflozin Compositions for Niche Environments
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to specialized pharmaceutical compositions of Canagliflozin adapted for specific, narrow markets or unique operational environments, such as high-security needs, disaster relief, or extreme weather conditions.
Background and Problem Solved
The original patent disclosed a stable pharmaceutical composition of Canagliflozin, but it has limitations in terms of its applicability in niche environments. The present inventive concept addresses these limitations by providing specialized compositions that can withstand extreme temperature fluctuations, high-humidity environments, and other challenging conditions.
Detailed Description of the Inventive Concept
The new inventive concept comprises a system for delivering Canagliflozin in high-altitude environments, a method for treating patients in disaster relief zones, a pharmaceutical composition for use in extreme weather conditions, a system for securing pharmaceutical compositions in high-security environments, and a method for treating patients in remote or isolated areas. These specialized compositions are formulated to be stable in challenging environments and provide a reliable treatment option for patients in need.
Novelty and Inventive Step
The new inventive concept provides a novel and non-obvious solution by adapting the original composition to specific niche environments, thereby expanding its applicability and value. The inventive step lies in the recognition of the need for specialized compositions and the development of formulations that can withstand extreme conditions.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include compositions adapted for use in space exploration, military operations, or other unique environments. Variations of the composition could include different ratios of excipients, alternative coating materials, or modified manufacturing processes.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of disaster relief, extreme weather response, and high-security environments. The target market includes government agencies, non-profit organizations, and private companies operating in these niches.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation and drug delivery systems, specifically focused on SGLT2 inhibitor compositions with emphasis on stability, excipient interactions, and environmental adaptability
Person of Ordinary Skill (PHOSITA) Profile
A pharmaceutical formulation scientist with expertise in drug stability, excipient selection, coating technologies, and environmental adaptation strategies for pharmaceutical compositions, typically holding a PhD or equivalent industrial experience in pharmaceutical sciences
Obviousness Rationale
A PHOSITA would recognize that the source patent's foundational composition of amorphous canagliflozin with specific excipients provides a predictable template for environmental adaptation. The disclosed variations represent routine engineering modifications to extend the composition's utility across different operational contexts. The core formulation strategy remains consistent, with minor adjustments to address specific environmental challenges.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,559 |
|---|---|
| Title | Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof |
| Assignee(s) | Aurobindo Pharma Ltd |